Replies to post #61461 on Biotech Values

[DewDiligence]

MNTA – SVP John Bishop sold 9,375 shares
today at $13 pursuant to his 10b5-1 plan:

http://www.sec.gov/Archives/edgar/data/1235010/000117911008008165/xslF345X02/edgar.xml

I hate these 10b5-1 plans and wish the SEC
would ban them.

[DewDiligence]

MNTA Insider Shareholdings
(*10b5-1 selling plan in effect)
(**Resigning effective 4-Jun-2008)

[Updated for Form-4 filings through 4/24/08.]

 
 Executive Officers  
 Craig Wheeler, CEO         350K shares   475K options 
 G. Venkataraman, CSO       477K shares   145K options 
 Steven Brugger, COO        263K shares   168K options 
 *John Bishop, SVP Pharma    39K shares   204K options 
 James Roach, CMO              0 shares   163K options 
 Richard Shea, CFO           28K shares   208K options 
 -- 
 Six executive officers   1,157K shares 1,363K options

 
 Non-executive directors  
 Peter Barrett (Atlas)    2,459K shares    77K options 
 John Clarke (Cardinal Prt) 477K shares    77K options 
 Alan Crane (Polaris)       586K shares    54K options 
 Marsha Fanucci                0 shares    77K options 
 Peter Hutt                  67K shares   156K options 
 Robert Langer              970K shares    77K options 
 **Stephen Reeders (MVM)    483K shares    77K options 
 *Ram Sasisekharan          406K shares    77K options 
 *Bennett Shapiro             7K shares   109K options 
 Elizabeth Stoner              0 shares    30K options 
 -- 
 10 non-executive dirctrs 5,455K shares   811K options

 
 All officers/directors   6,612K shares 2,174K options